Ocular Therapeutix (OCUL) Change in Receivables (2013 - 2026)
Ocular Therapeutix's quarterly Change in Receivables came in at -$6.3 million in Q1 2026, up 12.06% year-on-year from -$5.6 million in Q1 2025, and down 5241.53% quarter-over-quarter from -$118000.0 in Q4 2025.
Ocular Therapeutix has reported Change in Receivables for 14 years, with the latest figure at -$6.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 12.06% year-over-year to -$6.3 million; the trailing twelve-month figure through Mar 2026 stood at -$874000.0 (up 34.04% YoY), and the FY2025 full-year result was -$1.7 million, down 127.99% from the prior year.
- Change in Receivables for Q1 2026 stood at -$6.3 million, down from -$118000.0 in the prior quarter.
- The five-year high for Change in Receivables was $6.2 million in Q2 2023, with the low at -$7.2 million in Q1 2025.
- Average Change in Receivables over 5 years is $188941.2, with a median of $356000.0 recorded in 2025.
- Peak annual rise in Change in Receivables reached 11766.67% in 2025, while the deepest fall reached 2052.86% in 2025.
- Tracing OCUL's Change in Receivables over 5 years: stood at $1.5 million in 2022, then surged by 70.06% to $2.6 million in 2023, then retreated by 16.87% to $2.2 million in 2024, then plunged by 105.48% to -$118000.0 in 2025, then tumbled by 5241.53% to -$6.3 million in 2026.
- The last three Change in Receivables figures came in at -$6.3 million (Q1 2026), -$118000.0 (Q4 2025), and $356000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.30 Mn |
| Mar 31, 2026 | -6.30 Mn |
| Dec 31, 2025 | -118,000.00 |
| Dec 31, 2025 | -118,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | -7.17 Mn |
| Mar 31, 2025 | -7.17 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 367,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 2.59 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | -3.72 Mn |
| Sep 30, 2023 | -3.72 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | -201,000.00 |
| Mar 31, 2023 | -201,000.00 |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | -680,000.00 |
| Sep 30, 2022 | -680,000.00 |
| Jun 30, 2022 | -2.73 Mn |
| Jun 30, 2022 | -2.73 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 818,000.00 |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | 5.10 Mn |
| Jun 30, 2021 | 5.10 Mn |
| Mar 31, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.38 Mn |
| Dec 31, 2020 | 4.47 Mn |
| Dec 31, 2020 | 4.47 Mn |
| Sep 30, 2020 | 4.91 Mn |
| Sep 30, 2020 | 4.91 Mn |
| Jun 30, 2020 | -555,000.00 |
| Jun 30, 2020 | -555,000.00 |
| Mar 31, 2020 | 881,000.00 |
| Mar 31, 2020 | 881,000.00 |
| Dec 31, 2019 | 1.43 Mn |
| Dec 31, 2019 | 1.43 Mn |
| Sep 30, 2019 | 499,000.00 |
| Sep 30, 2019 | 499,000.00 |
| Jun 30, 2019 | 339,000.00 |
| Jun 30, 2019 | 339,000.00 |
| Mar 31, 2019 | 75,000.00 |
| Mar 31, 2019 | 75,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Sep 30, 2018 | -45,000.00 |
| Sep 30, 2018 | -45,000.00 |
| Jun 30, 2018 | 115,000.00 |
| Jun 30, 2018 | 115,000.00 |
| Mar 31, 2018 | -56,000.00 |
| Mar 31, 2018 | -56,000.00 |
| Dec 31, 2017 | -52,000.00 |
| Dec 31, 2017 | -52,000.00 |
| Sep 30, 2017 | 67,000.00 |
| Sep 30, 2017 | 67,000.00 |
| Jun 30, 2017 | -33,000.00 |
| Jun 30, 2017 | -33,000.00 |
| Mar 31, 2017 | -6,000.00 |
| Mar 31, 2017 | -6,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | -4,000.00 |
| Jun 30, 2016 | -4,000.00 |
| Mar 31, 2016 | 34,000.00 |
| Mar 31, 2016 | 34,000.00 |
| Dec 31, 2015 | 4,000.00 |
| Dec 31, 2015 | 4,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Jun 30, 2015 | -188,000.00 |
| Jun 30, 2015 | -188,000.00 |
| Mar 31, 2015 | 23,000.00 |
| Mar 31, 2015 | 23,000.00 |
| Dec 31, 2014 | 97,000.00 |
| Dec 31, 2014 | 97,000.00 |
| Jun 30, 2014 | -44,000.00 |
| Jun 30, 2014 | -44,000.00 |
| Mar 31, 2014 | 26,000.00 |
| Mar 31, 2014 | 26,000.00 |
| Dec 31, 2013 | 217,000.00 |
| Dec 31, 2013 | 217,000.00 |
| Sep 30, 2013 | 60,000.00 |
| Sep 30, 2013 | 60,000.00 |